Heimdall Insights

Global Bladder Cancer Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Bladder Cancer Market was valued at $4.8 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 8.5% CAGR, to an estimated market size of $7.2 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global bladder cancer market encompasses the diagnosis, treatment, and management of various forms of bladder cancer, primarily urothelial carcinoma, as well as squamous cell and adenocarcinoma. The scope includes therapeutic interventions such as immunotherapy, chemotherapy, targeted therapies, and antibody-drug conjugates (ADCs), alongside diagnostic tools like cystoscopy, biomarker testing, and surgical procedures like TURBT.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Bladder Cancer Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Immunotherapy
  • Chemotherapy
  • Targeted Therapy
  • Surgery & Others